课题基金 / 基金详情

Receptor-Targeted Photosensitzers for PDT of Cancers

Receptor-Targeted Photosensitzers for PDT of Cancers
用于癌症 PDT 的受体靶向光敏剂
批准号:
6789200
负责人:
HARIPRASAD GALI
金额:
$12.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-16 至 2005-04-30

项目摘要

项目成果

HARIPRASAD GALI的其他基金

相关文献

中文摘要
翻译
描述(申请人提供):光动力疗法(PDT)是治疗癌症的新兴方法之一。目前FDA批准用于癌症治疗的光敏剂(Photofrin)的局限性包括长期的皮肤光毒性、复杂的化合物混合物和相对较低的治疗窗口吸收。此外,Photofrin/R对播散性卵巢癌等腔内肿瘤没有选择性。在这个项目中,Lynntech在合理设计的基础上开发了一种新的受体靶向光敏剂。在这个设计中,远红外线吸收光敏剂通过连接物共价连接到受体靶向部分。所选择的靶向部分以高选择性和亲和力结合在癌细胞上过度表达的受体。作为概念的证明,在第一阶段,Lynntech将通过合成两种新的光敏剂共轭化合物来证明这项技术的可行性。这些结合物将在人卵巢癌细胞系中进行体外细胞摄取和光毒性测试。这项拟议的项目可能会导致开发一种临床上有用的药物来治疗各种人类癌症。这将对癌症患者的生存产生重大影响,在SBIR项目期间开发的技术可能每年用于治疗数千名癌症患者。
英文摘要
DESCRIPTION (provided by applicant): Photodynamic Therapy (PDT) is one of the emerging modalities for the treatment of cancer. Limitations associated with the current FDA approved photosensitizer (Photofrin) for cancer treatment includes prolonged cutaneous phototoxicity, complex mixture of compounds, and relatively low absorption in therapeutic window. In addition, Photofrin/R shows no selectivity for intracavity tumors such as disseminated ovarian cancers. During this project, Lynntech develops a new receptor-targeted photosensitizer based on a rational design. In this design, a far-red absorbing photosensitizer is covalently attached to a receptor-targeting moiety via a linker. The selected targeting moiety binds receptors that are overexpressed on the cancer cells with high selectivity and affinity. As a proof of the concept, during the Phase I, Lynntech will demonstrate the feasibility of this technology by synthesizing two new photosensitizer conjugates. These conjugates will be tested for in vitro cellular uptake and phototoxicity in a human ovarian cancer cell line. The proposed project could lead to the development of a clinically useful agent for the treatment of various human cancers. This will have a significant impact on the survival of cancer patients and the technology developed during this SBIR project could potentially be used for treating several thousands of cancer patients each year.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nanoporous Sorbents for Mercury Removal from Flue Gases
  • 批准号:
    6990840
  • 项目类别:
  • 资助金额:
    $11.56万
  • 财政年份:
    2006
  • 负责人:
    HARIPRASAD GALI
  • 依托单位:
Inorganic Ion Exchanger for use in 82Sr/82Rb Separations
  • 批准号:
    6405820
  • 项目类别:
  • 资助金额:
    $38.42万
  • 财政年份:
    2000
  • 负责人:
    HARIPRASAD GALI
  • 依托单位:
Inorganic Ion Exchanger for use in 82Sr/82Rb Separations
  • 批准号:
    6529862
  • 项目类别:
  • 资助金额:
    $39.75万
  • 财政年份:
    2000
  • 负责人:
    HARIPRASAD GALI
  • 依托单位: